News
According to two Canadian government officials cited by Politico, Ottawa will no longer proceed with plans to double its ...
Investing.com -- Ultragenyx Pharmaceutical (TADAWUL: 2070) Inc. (NASDAQ: RARE) stock fell over 5% after the company announced that the U.S. Food and Drug Administration (FDA) has issued a Complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results